<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1996-02-01" modified="2020-10-07" version="216">
<accession>Q08209</accession>
<accession>A1A441</accession>
<accession>A8K3B7</accession>
<accession>A8W6Z7</accession>
<accession>A8W6Z8</accession>
<accession>B5BUA2</accession>
<accession>Q8TAW9</accession>
<name>PP2BA_HUMAN</name>
<protein>
<recommendedName>
<fullName>Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform</fullName>
<ecNumber evidence="23 28 29 32 47">3.1.3.16</ecNumber>
</recommendedName>
<alternativeName>
<fullName>CAM-PRP catalytic subunit</fullName>
</alternativeName>
<alternativeName>
<fullName>Calmodulin-dependent calcineurin A subunit alpha isoform</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary" evidence="49">PPP3CA</name>
<name type="synonym">CALNA</name>
<name type="synonym">CNA</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1993" name="Biochim. Biophys. Acta" volume="1178" first="117" last="120">
<title>Molecular cloning of a full-length cDNA encoding the catalytic subunit of human calmodulin-dependent protein phosphatase (calcineurin A alpha).</title>
<authorList>
<person name="Muramatsu T."/>
<person name="Kincaid R.L."/>
</authorList>
<dbReference type="PubMed" id="8392375"/>
<dbReference type="DOI" id="10.1016/0167-4889(93)90117-8"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2010" name="Subst. Use Misuse" volume="45" first="1809" last="1826">
<title>Fine mapping of calcineurin (PPP3CA) gene reveals novel alternative splicing patterns, association of 5'UTR trinucleotide repeat with addiction vulnerability, and differential isoform expression in Alzheimer's disease.</title>
<authorList>
<person name="Chiocco M.J."/>
<person name="Zhu X."/>
<person name="Walther D."/>
<person name="Pletnikova O."/>
<person name="Troncoso J.C."/>
<person name="Uhl G.R."/>
<person name="Liu Q.R."/>
</authorList>
<dbReference type="PubMed" id="20590401"/>
<dbReference type="DOI" id="10.3109/10826084.2010.482449"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 3 AND 4)</scope>
<scope>ALTERNATIVE SPLICING</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2011" name="Mol. Vis." volume="17" first="1324" last="1333">
<title>Identification of differentially expressed genes in uveal melanoma using suppressive subtractive hybridization.</title>
<authorList>
<person name="Landreville S."/>
<person name="Lupien C.B."/>
<person name="Vigneault F."/>
<person name="Gaudreault M."/>
<person name="Mathieu M."/>
<person name="Rousseau A.P."/>
<person name="Guerin S.L."/>
<person name="Salesse C."/>
</authorList>
<dbReference type="PubMed" id="21647268"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="5">
<citation type="journal article" date="2007" name="BMC Genomics" volume="8" first="399" last="399">
<title>The full-ORF clone resource of the German cDNA consortium.</title>
<authorList>
<person name="Bechtel S."/>
<person name="Rosenfelder H."/>
<person name="Duda A."/>
<person name="Schmidt C.P."/>
<person name="Ernst U."/>
<person name="Wellenreuther R."/>
<person name="Mehrle A."/>
<person name="Schuster C."/>
<person name="Bahr A."/>
<person name="Bloecker H."/>
<person name="Heubner D."/>
<person name="Hoerlein A."/>
<person name="Michel G."/>
<person name="Wedler H."/>
<person name="Koehrer K."/>
<person name="Ottenwaelder B."/>
<person name="Poustka A."/>
<person name="Wiemann S."/>
<person name="Schupp I."/>
</authorList>
<dbReference type="PubMed" id="17974005"/>
<dbReference type="DOI" id="10.1186/1471-2164-8-399"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Amygdala</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2008" name="Nat. Methods" volume="5" first="1011" last="1017">
<title>Human protein factory for converting the transcriptome into an in vitro-expressed proteome.</title>
<authorList>
<person name="Goshima N."/>
<person name="Kawamura Y."/>
<person name="Fukumoto A."/>
<person name="Miura A."/>
<person name="Honma R."/>
<person name="Satoh R."/>
<person name="Wakamatsu A."/>
<person name="Yamamoto J."/>
<person name="Kimura K."/>
<person name="Nishikawa T."/>
<person name="Andoh T."/>
<person name="Iida Y."/>
<person name="Ishikawa K."/>
<person name="Ito E."/>
<person name="Kagawa N."/>
<person name="Kaminaga C."/>
<person name="Kanehori K."/>
<person name="Kawakami B."/>
<person name="Kenmochi K."/>
<person name="Kimura R."/>
<person name="Kobayashi M."/>
<person name="Kuroita T."/>
<person name="Kuwayama H."/>
<person name="Maruyama Y."/>
<person name="Matsuo K."/>
<person name="Minami K."/>
<person name="Mitsubori M."/>
<person name="Mori M."/>
<person name="Morishita R."/>
<person name="Murase A."/>
<person name="Nishikawa A."/>
<person name="Nishikawa S."/>
<person name="Okamoto T."/>
<person name="Sakagami N."/>
<person name="Sakamoto Y."/>
<person name="Sasaki Y."/>
<person name="Seki T."/>
<person name="Sono S."/>
<person name="Sugiyama A."/>
<person name="Sumiya T."/>
<person name="Takayama T."/>
<person name="Takayama Y."/>
<person name="Takeda H."/>
<person name="Togashi T."/>
<person name="Yahata K."/>
<person name="Yamada H."/>
<person name="Yanagisawa Y."/>
<person name="Endo Y."/>
<person name="Imamoto F."/>
<person name="Kisu Y."/>
<person name="Tanaka S."/>
<person name="Isogai T."/>
<person name="Imai J."/>
<person name="Watanabe S."/>
<person name="Nomura N."/>
</authorList>
<dbReference type="PubMed" id="19054851"/>
<dbReference type="DOI" id="10.1038/nmeth.1273"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="8">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Pancreas</tissue>
</source>
</reference>
<reference key="10">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="14632" last="14637">
<title>Calsarcins, a novel family of sarcomeric calcineurin-binding proteins.</title>
<authorList>
<person name="Frey N."/>
<person name="Richardson J.A."/>
<person name="Olson E.N."/>
</authorList>
<dbReference type="PubMed" id="11114196"/>
<dbReference type="DOI" id="10.1073/pnas.260501097"/>
</citation>
<scope>INTERACTION WITH MYOZ1 AND MYOZ2</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="13998" last="14004">
<title>Calsarcin-3, a novel skeletal muscle-specific member of the calsarcin family, interacts with multiple Z-disc proteins.</title>
<authorList>
<person name="Frey N."/>
<person name="Olson E.N."/>
</authorList>
<dbReference type="PubMed" id="11842093"/>
<dbReference type="DOI" id="10.1074/jbc.m200712200"/>
</citation>
<scope>INTERACTION WITH MYOZ3</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2003" name="Biochem. J." volume="374" first="567" last="575">
<title>Phosphorylation of calcipressin 1 increases its ability to inhibit calcineurin and decreases calcipressin half-life.</title>
<authorList>
<person name="Genesca L."/>
<person name="Aubareda A."/>
<person name="Fuentes J.J."/>
<person name="Estivill X."/>
<person name="De La Luna S."/>
<person name="Perez-Riba M."/>
</authorList>
<dbReference type="PubMed" id="12809556"/>
<dbReference type="DOI" id="10.1042/bj20030267"/>
</citation>
<scope>INTERACTION WITH RCAN1</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2004" name="Cell" volume="119" first="61" last="74">
<title>The CREB coactivator TORC2 functions as a calcium- and cAMP-sensitive coincidence detector.</title>
<authorList>
<person name="Screaton R.A."/>
<person name="Conkright M.D."/>
<person name="Katoh Y."/>
<person name="Best J.L."/>
<person name="Canettieri G."/>
<person name="Jeffries S."/>
<person name="Guzman E."/>
<person name="Niessen S."/>
<person name="Yates J.R. III"/>
<person name="Takemori H."/>
<person name="Okamoto M."/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="15454081"/>
<dbReference type="DOI" id="10.1016/j.cell.2004.09.015"/>
</citation>
<scope>INTERACTION WITH CRTC2</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2005" name="J. Biol. Chem." volume="280" first="12683" last="12689">
<title>Calcium signal-induced cofilin dephosphorylation is mediated by Slingshot via calcineurin.</title>
<authorList>
<person name="Wang Y."/>
<person name="Shibasaki F."/>
<person name="Mizuno K."/>
</authorList>
<dbReference type="PubMed" id="15671020"/>
<dbReference type="DOI" id="10.1074/jbc.m411494200"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2007" name="Mol. Cell. Biol." volume="27" first="8215" last="8227">
<title>Protein kinase A, Ca2+/calmodulin-dependent kinase II, and calcineurin regulate the intracellular trafficking of myopodin between the Z-disc and the nucleus of cardiac myocytes.</title>
<authorList>
<person name="Faul C."/>
<person name="Dhume A."/>
<person name="Schecter A.D."/>
<person name="Mundel P."/>
</authorList>
<dbReference type="PubMed" id="17923693"/>
<dbReference type="DOI" id="10.1128/mcb.00950-07"/>
</citation>
<scope>INTERACTION WITH SYNPO2</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="15803" last="15808">
<title>Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria.</title>
<authorList>
<person name="Cereghetti G.M."/>
<person name="Stangherlin A."/>
<person name="Martins de Brito O."/>
<person name="Chang C.R."/>
<person name="Blackstone C."/>
<person name="Bernardi P."/>
<person name="Scorrano L."/>
</authorList>
<dbReference type="PubMed" id="18838687"/>
<dbReference type="DOI" id="10.1073/pnas.0808249105"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH DMN1L</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2009" name="Biochemistry" volume="48" first="1900" last="1910">
<title>The proline-rich N-terminal sequence of calcineurin Abeta determines substrate binding.</title>
<authorList>
<person name="Kilka S."/>
<person name="Erdmann F."/>
<person name="Migdoll A."/>
<person name="Fischer G."/>
<person name="Weiwad M."/>
</authorList>
<dbReference type="PubMed" id="19154138"/>
<dbReference type="DOI" id="10.1021/bi8019355"/>
</citation>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>BIOPHYSICOCHEMICAL PROPERTIES</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-492</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="21">
<citation type="journal article" date="2017" name="Am. J. Hum. Genet." volume="101" first="516" last="524">
<title>De Novo Mutations in PPP3CA Cause Severe Neurodevelopmental Disease with Seizures.</title>
<authorList>
<person name="Myers C.T."/>
<person name="Stong N."/>
<person name="Mountier E.I."/>
<person name="Helbig K.L."/>
<person name="Freytag S."/>
<person name="Sullivan J.E."/>
<person name="Ben Zeev B."/>
<person name="Nissenkorn A."/>
<person name="Tzadok M."/>
<person name="Heimer G."/>
<person name="Shinde D.N."/>
<person name="Rezazadeh A."/>
<person name="Regan B.M."/>
<person name="Oliver K.L."/>
<person name="Ernst M.E."/>
<person name="Lippa N.C."/>
<person name="Mulhern M.S."/>
<person name="Ren Z."/>
<person name="Poduri A."/>
<person name="Andrade D.M."/>
<person name="Bird L.M."/>
<person name="Bahlo M."/>
<person name="Berkovic S.F."/>
<person name="Lowenstein D.H."/>
<person name="Scheffer I.E."/>
<person name="Sadleir L.G."/>
<person name="Goldstein D.B."/>
<person name="Mefford H.C."/>
<person name="Heinzen E.L."/>
</authorList>
<dbReference type="PubMed" id="28942967"/>
<dbReference type="DOI" id="10.1016/j.ajhg.2017.08.013"/>
</citation>
<scope>INVOLVEMENT IN IECEE1</scope>
<scope>VARIANTS IECEE1 ARG-92; GLN-281; LYS-282; 445-GLN--GLN-521 DEL AND THR-447</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2017" name="Elife" volume="6">
<title>A protein phosphatase network controls the temporal and spatial dynamics of differentiation commitment in human epidermis.</title>
<authorList>
<person name="Mishra A."/>
<person name="Oules B."/>
<person name="Pisco A.O."/>
<person name="Ly T."/>
<person name="Liakath-Ali K."/>
<person name="Walko G."/>
<person name="Viswanathan P."/>
<person name="Tihy M."/>
<person name="Nijjher J."/>
<person name="Dunn S.J."/>
<person name="Lamond A.I."/>
<person name="Watt F.M."/>
</authorList>
<dbReference type="PubMed" id="29043977"/>
<dbReference type="DOI" id="10.7554/elife.27356"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2018" name="IScience" volume="11" first="134" last="145">
<title>Mitogenic Signals Stimulate the CREB Coactivator CRTC3 through PP2A Recruitment.</title>
<authorList>
<person name="Sonntag T."/>
<person name="Ostojic J."/>
<person name="Vaughan J.M."/>
<person name="Moresco J.J."/>
<person name="Yoon Y.S."/>
<person name="Yates J.R. III"/>
<person name="Montminy M."/>
</authorList>
<dbReference type="PubMed" id="30611118"/>
<dbReference type="DOI" id="10.1016/j.isci.2018.12.012"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH CRTC1 AND CRTC2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="1995" name="Nature" volume="378" first="641" last="644">
<title>Crystal structures of human calcineurin and the human FKBP12-FK506-calcineurin complex.</title>
<authorList>
<person name="Kissinger C.R."/>
<person name="Parge H.E."/>
<person name="Knighton D.R."/>
<person name="Lewis C.T."/>
<person name="Pelletier L.A."/>
<person name="Tempczyk A."/>
<person name="Kalish V.J."/>
<person name="Tucker K.D."/>
<person name="Showalter R.E."/>
<person name="Moomaw E.W."/>
<person name="Gastinel L.N."/>
<person name="Habuka N."/>
<person name="Chen X."/>
<person name="Maldonado F."/>
<person name="Barker J.E."/>
<person name="Bacquet R."/>
<person name="Villafranca J.E."/>
</authorList>
<dbReference type="PubMed" id="8524402"/>
<dbReference type="DOI" id="10.1038/378641a0"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEX WITH PPP3R1; IRON AND ZINC</scope>
<scope>ACTIVE SITE</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="12037" last="12042">
<title>Crystal structure of calcineurin-cyclophilin-cyclosporin shows common but distinct recognition of immunophilin-drug complexes.</title>
<authorList>
<person name="Huai Q."/>
<person name="Kim H.Y."/>
<person name="Liu Y."/>
<person name="Zhao Y."/>
<person name="Mondragon A."/>
<person name="Liu J.O."/>
<person name="Ke H."/>
</authorList>
<dbReference type="PubMed" id="12218175"/>
<dbReference type="DOI" id="10.1073/pnas.192206699"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 1-372 IN COMPLEX WITH PPIA; PPP3R1; IRON AND ZINC</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2002" name="Proc. Natl. Acad. Sci. U.S.A." volume="99" first="13522" last="13526">
<title>Crystal structure of human calcineurin complexed with cyclosporin A and human cyclophilin.</title>
<authorList>
<person name="Jin L."/>
<person name="Harrison S.C."/>
</authorList>
<dbReference type="PubMed" id="12357034"/>
<dbReference type="DOI" id="10.1073/pnas.212504399"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.10 ANGSTROMS) OF 20-392 IN COMPLEX WITH PPIA AND PPP3R1</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2007" name="J. Mol. Biol." volume="369" first="1296" last="1306">
<title>Structure of calcineurin in complex with PVIVIT peptide: portrait of a low-affinity signalling interaction.</title>
<authorList>
<person name="Li H."/>
<person name="Zhang L."/>
<person name="Rao A."/>
<person name="Harrison S.C."/>
<person name="Hogan P.G."/>
</authorList>
<dbReference type="PubMed" id="17498738"/>
<dbReference type="DOI" id="10.1016/j.jmb.2007.04.032"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 1-380 IN COMPLEX WITH SUBSTRATE PEPTIDE; PPP3R1; IRON AND ZINC</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2007" name="Structure" volume="15" first="587" last="597">
<title>Structure of the calcineurin-NFAT complex: defining a T cell activation switch using solution NMR and crystal coordinates.</title>
<authorList>
<person name="Takeuchi K."/>
<person name="Roehrl M.H."/>
<person name="Sun Z.Y."/>
<person name="Wagner G."/>
</authorList>
<dbReference type="PubMed" id="17502104"/>
<dbReference type="DOI" id="10.1016/j.str.2007.03.015"/>
</citation>
<scope>STRUCTURE BY NMR OF 21-347 IN COMPLEX WITH PEPTIDE SUBSTRATE</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="Proteins" volume="73" first="19" last="27">
<title>The complex structure of calmodulin bound to a calcineurin peptide.</title>
<authorList>
<person name="Ye Q."/>
<person name="Wang H."/>
<person name="Zheng J."/>
<person name="Wei Q."/>
<person name="Jia Z."/>
</authorList>
<dbReference type="PubMed" id="18384083"/>
<dbReference type="DOI" id="10.1002/prot.22032"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS) OF 389-413 IN COMPLEX WITH CALM1</scope>
</reference>
<reference key="30">
<citation type="submission" date="2008-01" db="PDB data bank">
<title>Structure of Calmodulin complexed with the Calmodulin Binding Domain of Calcineurin.</title>
<authorList>
<person name="Chyan C."/>
<person name="Huang J."/>
<person name="Irene D."/>
<person name="Lin T."/>
</authorList>
</citation>
<scope>STRUCTURE BY NMR OF 391-414 IN COMPLEX WITH CALM1</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2009" name="PLoS ONE" volume="4" first="E5402" last="E5402">
<title>Domain swapping and different oligomeric States for the complex between calmodulin and the calmodulin-binding domain of calcineurin a.</title>
<authorList>
<person name="Majava V."/>
<person name="Kursula P."/>
</authorList>
<dbReference type="PubMed" id="19404396"/>
<dbReference type="DOI" id="10.1371/journal.pone.0005402"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) OF 395-411 IN COMPLEX WITH CALM1</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2012" name="Nat. Struct. Mol. Biol." volume="19" first="337" last="345">
<title>Balanced interactions of calcineurin with AKAP79 regulate Ca2+-calcineurin-NFAT signaling.</title>
<authorList>
<person name="Li H."/>
<person name="Pink M.D."/>
<person name="Murphy J.G."/>
<person name="Stein A."/>
<person name="Dell'Acqua M.L."/>
<person name="Hogan P.G."/>
</authorList>
<dbReference type="PubMed" id="22343722"/>
<dbReference type="DOI" id="10.1038/nsmb.2238"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 14-370 IN COMPLEX WITH PPP3R1; AKAP5 PEPTIDE; IRON AND ZINC</scope>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2013" name="PLoS Biol." volume="11" first="E1001492" last="E1001492">
<title>The molecular mechanism of substrate engagement and immunosuppressant inhibition of calcineurin.</title>
<authorList>
<person name="Grigoriu S."/>
<person name="Bond R."/>
<person name="Cossio P."/>
<person name="Chen J.A."/>
<person name="Ly N."/>
<person name="Hummer G."/>
<person name="Page R."/>
<person name="Cyert M.S."/>
<person name="Peti W."/>
</authorList>
<dbReference type="PubMed" id="23468591"/>
<dbReference type="DOI" id="10.1371/journal.pbio.1001492"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF 1-370 IN COMPLEX WITH PPP3R1 AND AFRICAN SWINE FEVER VIRUS MAL-047/A238L</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2014" name="Biochemistry" volume="53" first="5779" last="5790">
<title>Stoichiometry of the calcineurin regulatory domain-calmodulin complex.</title>
<authorList>
<person name="Dunlap T.B."/>
<person name="Guo H.F."/>
<person name="Cook E.C."/>
<person name="Holbrook E."/>
<person name="Rumi-Masante J."/>
<person name="Lester T.E."/>
<person name="Colbert C.L."/>
<person name="Vander Kooi C.W."/>
<person name="Creamer T.P."/>
</authorList>
<dbReference type="PubMed" id="25144868"/>
<dbReference type="DOI" id="10.1021/bi5004734"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 391-414 IN COMPLEX WITH CALM1</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2015" name="PLoS ONE" volume="10" first="E0134569" last="E0134569">
<title>Calcineurin Undergoes a Conformational Switch Evoked via Peptidyl-Prolyl Isomerization.</title>
<authorList>
<person name="Guasch A."/>
<person name="Aranguren-Ibanez A."/>
<person name="Perez-Luque R."/>
<person name="Aparicio D."/>
<person name="Martinez-Hoyer S."/>
<person name="Mulero M.C."/>
<person name="Serrano-Candelas E."/>
<person name="Perez-Riba M."/>
<person name="Fita I."/>
</authorList>
<dbReference type="PubMed" id="26248042"/>
<dbReference type="DOI" id="10.1371/journal.pone.0134569"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (3.35 ANGSTROMS) OF 2-346 IN COMPLEX WITH IRON AND ZINC</scope>
<scope>FUNCTION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>INTERACTION WITH RCAN3 AND NFATC2</scope>
<scope>MOTIF</scope>
<scope>MUTAGENESIS OF TYR-288; TYR-341 AND 328-VAL--ARG-332</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2016" name="Sci. Rep." volume="6" first="38920" last="38920">
<title>Investigating the human Calcineurin Interaction Network using the piLxVP SLiM.</title>
<authorList>
<person name="Sheftic S.R."/>
<person name="Page R."/>
<person name="Peti W."/>
</authorList>
<dbReference type="PubMed" id="27974827"/>
<dbReference type="DOI" id="10.1038/srep38920"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.60 ANGSTROMS) OF 1-370 IN COMPLEX WITH PPP3R1; PEPTIDE SUBSTRATE; IRON AND ZINC</scope>
<scope>FUNCTION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2018" name="Hum. Mol. Genet." volume="27" first="1421" last="1433">
<title>Loss-of-function and gain-of-function mutations in PPP3CA cause two distinct disorders.</title>
<authorList>
<person name="Mizuguchi T."/>
<person name="Nakashima M."/>
<person name="Kato M."/>
<person name="Okamoto N."/>
<person name="Kurahashi H."/>
<person name="Ekhilevitch N."/>
<person name="Shiina M."/>
<person name="Nishimura G."/>
<person name="Shibata T."/>
<person name="Matsuo M."/>
<person name="Ikeda T."/>
<person name="Ogata K."/>
<person name="Tsuchida N."/>
<person name="Mitsuhashi S."/>
<person name="Miyatake S."/>
<person name="Takata A."/>
<person name="Miyake N."/>
<person name="Hata K."/>
<person name="Kaname T."/>
<person name="Matsubara Y."/>
<person name="Saitsu H."/>
<person name="Matsumoto N."/>
</authorList>
<dbReference type="PubMed" id="29432562"/>
<dbReference type="DOI" id="10.1093/hmg/ddy052"/>
</citation>
<scope>VARIANTS ACCIID LEU-470 AND THR-473</scope>
<scope>INVOLVEMENT IN ACCIID</scope>
<scope>VARIANTS IECEE1 ARG-92; ILE-150 AND GLU-234</scope>
</reference>
<comment type="function">
<text evidence="14 23 24 25 28 29 31 32 34 35 39">Calcium-dependent, calmodulin-stimulated protein phosphatase which plays an essential role in the transduction of intracellular Ca(2+)-mediated signals (PubMed:15671020, PubMed:18838687, PubMed:19154138, PubMed:23468591). Many of the substrates contain a PxIxIT motif and/or a LxVP motif (PubMed:17498738, PubMed:17502104, PubMed:23468591, PubMed:27974827, PubMed:22343722). In response to increased Ca(2+) levels, dephosphorylates and activates phosphatase SSH1 which results in cofilin dephosphorylation (PubMed:15671020). In response to increased Ca(2+) levels following mitochondrial depolarization, dephosphorylates DNM1L inducing DNM1L translocation to the mitochondrion (PubMed:18838687). Dephosphorylates heat shock protein HSPB1 (By similarity). Dephosphorylates and activates transcription factor NFATC1 (PubMed:19154138). In response to increased Ca(2+) levels, regulates NFAT-mediated transcription probably by dephosphorylating NFAT and promoting its nuclear translocation (PubMed:26248042). Dephosphorylates and inactivates transcription factor ELK1 (PubMed:19154138). Dephosphorylates DARPP32 (PubMed:19154138). May dephosphorylate CRTC2 at 'Ser-171' resulting in CRTC2 dissociation from 14-3-3 proteins (PubMed:30611118).</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="23 28 29 32 47">
<text>H2O + O-phospho-L-seryl-[protein] = L-seryl-[protein] + phosphate</text>
<dbReference type="Rhea" id="RHEA:20629"/>
<dbReference type="Rhea" id="RHEA-COMP:9863"/>
<dbReference type="Rhea" id="RHEA-COMP:11604"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:29999"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:83421"/>
<dbReference type="EC" id="3.1.3.16"/>
</reaction>
</comment>
<comment type="catalytic activity">
<reaction evidence="23 28 29 32 47">
<text>H2O + O-phospho-L-threonyl-[protein] = L-threonyl-[protein] + phosphate</text>
<dbReference type="Rhea" id="RHEA:47004"/>
<dbReference type="Rhea" id="RHEA-COMP:11060"/>
<dbReference type="Rhea" id="RHEA-COMP:11605"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:30013"/>
<dbReference type="ChEBI" id="CHEBI:43474"/>
<dbReference type="ChEBI" id="CHEBI:61977"/>
<dbReference type="EC" id="3.1.3.16"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="19 24 31 34 35 40">
<name>Fe(3+)</name>
<dbReference type="ChEBI" id="CHEBI:29034"/>
</cofactor>
<text evidence="19 24 31 34 35 40">Binds 1 Fe(3+) ion per subunit.</text>
</comment>
<comment type="cofactor">
<cofactor evidence="19 24 31 34 35 40">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="19 24 31 34 35 40">Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="13 34">Activated by Ca(2+)-bound calmodulin following an increase in intracellular Ca(2+). At low Ca(2+) concentrations, the catalytic subunit (also known as calcineurin A) is inactive and is bound to the regulatory subunit (also known as calcineurin B) in which only two high-affinity binding sites are occupied by Ca(2+). In response to elevated calcium levels, the occupancy of the low-affinity sites on calcineurin B by Ca(2+) causes a conformational change of the C-terminal regulatory domain of calcineurin A, resulting in the exposure of the calmodulin-binding domain and in the partial activation of calcineurin A. The subsequent binding of Ca(2+)-bound calmodulin leads to the displacement of the autoinhibitory domain from the active site and possibly of the autoinhibitory segment from the substrate binding site which fully activates calcineurin A. Inhibited by immunosuppressant drug FK506 (tacrolimus) in complex with FKBP12 and also by immunosuppressant drug cyclosporin A (CsA) in complex with PPIA/cyclophilin A; the inhibition is Ca(2+)-dependent (PubMed:26248042).</text>
</comment>
<comment type="biophysicochemical properties">
<kinetics>
<KM evidence="29">2.04 uM for NFATC1</KM>
<KM evidence="29">2.22 uM for DARPP32</KM>
</kinetics>
</comment>
<comment type="subunit">
<text evidence="14 15 16 17 18 19 20 21 22 24 26 27 28 30 31 32 33 34 35 39 40 41">Forms a complex composed of a calmodulin-dependent catalytic subunit (also known as calcineurin A) and a regulatory Ca(2+)-binding subunit (also known as calcineurin B) (PubMed:8524402, PubMed:12218175, PubMed:12357034, PubMed:17498738, PubMed:22343722, PubMed:23468591, PubMed:27974827). There are three catalytic subunits, each encoded by a separate gene (PPP3CA, PPP3CB, and PPP3CC) and two regulatory subunits which are also encoded by separate genes (PPP3R1 and PPP3R2). In response to an increase in Ca(2+) intracellular levels, forms a complex composed of PPP3CA/calcineurin A, calcineurin B and calmodulin (By similarity). Interacts (via calcineurin B binding domain) with regulatory subunit PPP3R1/calcineurin B (PubMed:8524402, PubMed:12218175, PubMed:12357034, PubMed:17498738, PubMed:22343722, PubMed:23468591, PubMed:27974827). Interacts (via calmodulin-binding domain) with CALM1/calmodulin; the interaction depends on calmodulin binding to Ca(2+) (PubMed:18384083, Ref.30, PubMed:19404396, PubMed:25144868). Forms a complex composed of MYOZ2 and ACTN1 (By similarity). Within the complex interacts with MYOZ2 (PubMed:11114196). Interacts with MYOZ1 (PubMed:11114196). Interacts with MYOZ3 (PubMed:11842093). Interacts with CIB1; the interaction increases upon cardiomyocyte hypertrophy (By similarity). Interacts with CHP1 and CHP2 (By similarity). Interacts with CRTC1 (PubMed:30611118). Interacts with CRTC2 (PubMed:15454081, PubMed:30611118). Interacts with DNM1L; the interaction dephosphorylates DNM1L and promotes its translocation to mitochondria (PubMed:18838687). Interacts with CMYA5; this interaction represses calcineurin activity in muscle (By similarity). Interacts (constitutively active form) with SYNPO2 (PubMed:17923693). Interacts with scaffold protein AKAP5 (via IAIIIT motif); the interaction recruits PPP3CA to the plasma membrane following L-type Ca(2+)-channel activation (PubMed:22343722). Interacts with NFATC2 (PubMed:26248042). Interacts with RCAN3 (PubMed:26248042). Interacts with PPIA (PubMed:12218175, PubMed:12357034). Interacts with RCAN1 (PubMed:12809556). Interacts with UNC119 (By similarity).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-352922">
<id>Q08209</id>
</interactant>
<interactant intactId="EBI-10225238">
<id>R4GN89</id>
<label>C16orf74</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-352922">
<id>Q08209</id>
</interactant>
<interactant intactId="EBI-401755">
<id>P62993</id>
<label>GRB2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-352922">
<id>Q08209</id>
</interactant>
<interactant intactId="EBI-915984">
<id>P63098</id>
<label>PPP3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-352922">
<id>Q08209</id>
</interactant>
<interactant intactId="EBI-1048016">
<id>P54578</id>
<label>USP14</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-352922">
<id>Q08209</id>
</interactant>
<interactant intactId="EBI-9086576">
<id>Q8VHW5</id>
<label>Cacng8</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15637215">
<id>Q08209-1</id>
</interactant>
<interactant intactId="EBI-703640">
<id>P24588</id>
<label>AKAP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>6</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15637215">
<id>Q08209-1</id>
</interactant>
<interactant intactId="EBI-6907210">
<id>O95644</id>
<label>NFATC1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15637215">
<id>Q08209-1</id>
</interactant>
<interactant intactId="EBI-716258">
<id>Q13469</id>
<label>NFATC2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15637215">
<id>Q08209-1</id>
</interactant>
<interactant intactId="EBI-915984">
<id>P63098</id>
<label>PPP3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>7</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15637215">
<id>Q08209-1</id>
</interactant>
<interactant intactId="EBI-295856">
<id>P46939</id>
<label>UTRN</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-15637215">
<id>Q08209-1</id>
</interactant>
<interactant intactId="EBI-16039701">
<id>O36972</id>
<label>A238L</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-11096309">
<id>Q9NYB9-2</id>
<label>ABI2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-703640">
<id>P24588</id>
<label>AKAP5</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-7121510">
<id>P49418</id>
<label>AMPH</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-1046033">
<id>Q9H993</id>
<label>ARMT1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-745814">
<id>Q96GX8</id>
<label>C16orf74</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-10290462">
<id>Q96KS9</id>
<label>FAM167A</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-751388">
<id>P27987</id>
<label>ITPKB</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-915984">
<id>P63098</id>
<label>PPP3R1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>12</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-12859744">
<id>A0A494C014</id>
<label>PPP3R2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-11959011">
<id>Q9UPX8-4</id>
<label>SHANK2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-7543499">
<id>Q8IZW8</id>
<label>TNS4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-2341648">
<id>Q6ZMU5</id>
<label>TRIM72</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-711260">
<id>Q13432</id>
<label>UNC119</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-11959013">
<id>Q08209-2</id>
</interactant>
<interactant intactId="EBI-750454">
<id>Q96EJ4</id>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="29 31">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="31">Cell membrane</location>
<topology evidence="31">Peripheral membrane protein</topology>
</subcellularLocation>
<subcellularLocation>
<location evidence="16">Cell membrane</location>
<location evidence="16">Sarcolemma</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="16">Cytoplasm</location>
<location evidence="16">Myofibril</location>
<location evidence="16">Sarcomere</location>
<location evidence="16">Z line</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="31">Cell projection</location>
<location evidence="31">Dendritic spine</location>
</subcellularLocation>
<text evidence="16 31">Colocalizes with ACTN1 and MYOZ2 at the Z line in heart and skeletal muscle (By similarity). Recruited to the cell membrane by scaffold protein AKAP5 following L-type Ca(2+)-channel activation (PubMed:22343722).</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q08209-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q08209-2</id>
<name>2</name>
<sequence type="described" ref="VSP_018562"/>
</isoform>
<isoform>
<id>Q08209-3</id>
<name>3</name>
<sequence type="described" ref="VSP_043378 VSP_018562"/>
</isoform>
<isoform>
<id>Q08209-4</id>
<name>4</name>
<sequence type="described" ref="VSP_047755"/>
</isoform>
<isoform>
<id>Q08209-5</id>
<name>5</name>
<sequence type="described" ref="VSP_054467"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="37">Expressed in keratinocytes (at protein level).</text>
</comment>
<comment type="domain">
<text evidence="15">The autoinhibitory domain prevents access to the catalytic site.</text>
</comment>
<comment type="domain">
<text evidence="15">The autoinhibitory segment prevents access to the substrate binding site.</text>
</comment>
<comment type="domain">
<text evidence="34">Possible isomerization of Pro-309 within the SAPNY motif triggers a conformation switch which affects the organization and thus accessibility of the active site and the substrate binding region (PxIxIF motif). The trans- to cis-transition may favor calcineurin A activation and substrate binding. The reverse cis- to trans-transition may be enhanced by peptidyl-prolyl isomerases such as PPIA.</text>
</comment>
<comment type="disease" evidence="36 38">
<disease id="DI-05114">
<name>Epileptic encephalopathy, infantile or early childhood, 1</name>
<acronym>IECEE1</acronym>
<description>A form of epileptic encephalopathy, a heterogeneous group of severe childhood onset epilepsies characterized by refractory seizures, neurodevelopmental impairment, and poor prognosis. Development is normal prior to seizure onset, after which cognitive and motor delays become apparent. IECEE1 is an autosomal dominant condition with onset of seizures between the first weeks and first years of life.</description>
<dbReference type="MIM" id="617711"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="38">
<disease id="DI-05453">
<name>Arthrogryposis, cleft palate, craniosynostosis, and impaired intellectual development</name>
<acronym>ACCIID</acronym>
<description>An autosomal dominant disease characterized by moderate to severe intellectual disability, craniosynostosis, cleft palate, micrognathia, arthrogryposis, and short stature. Some patients may present bone abnormalities and generalized seizures.</description>
<dbReference type="MIM" id="618265"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text evidence="32">Although African swine fever virus infects pigs and not humans, human PPP3CA has been used for the crystallization. PPP3CA interacts with African swine fever virus Mal-047/A238L (via PKIIIT and FLCVK motifs); the interaction does not block catalytic activity per se but inhibits PPP3CA function by blocking the access to the two substrate recognition sites.</text>
</comment>
<comment type="similarity">
<text evidence="46">Belongs to the PPP phosphatase family. PP-2B subfamily.</text>
</comment>
<comment type="online information" name="Wikipedia">
<link uri="https://en.wikipedia.org/wiki/Calcineurin"/>
<text>Calcineurin entry</text>
</comment>
<dbReference type="EC" id="3.1.3.16" evidence="23 28 29 32 47"/>
<dbReference type="EMBL" id="L14778">
<property type="protein sequence ID" value="AAA02631.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU192652">
<property type="protein sequence ID" value="ABW74484.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EU192653">
<property type="protein sequence ID" value="ABW74485.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY904364">
<property type="protein sequence ID" value="AAY17314.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290532">
<property type="protein sequence ID" value="BAF83221.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AL353950">
<property type="protein sequence ID" value="CAB89253.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451338">
<property type="protein sequence ID" value="BAG70152.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AB451487">
<property type="protein sequence ID" value="BAG70301.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AC092671">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001816">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001870">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AP001939">
<property type="status" value="NOT_ANNOTATED_CDS"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471057">
<property type="protein sequence ID" value="EAX06125.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471057">
<property type="protein sequence ID" value="EAX06124.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC025714">
<property type="protein sequence ID" value="AAH25714.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS34037.1">
<molecule id="Q08209-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47113.1">
<molecule id="Q08209-3"/>
</dbReference>
<dbReference type="CCDS" id="CCDS47114.1">
<molecule id="Q08209-2"/>
</dbReference>
<dbReference type="PIR" id="S35067">
<property type="entry name" value="S35067"/>
</dbReference>
<dbReference type="RefSeq" id="NP_000935.1">
<molecule id="Q08209-1"/>
<property type="nucleotide sequence ID" value="NM_000944.4"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124163.1">
<molecule id="Q08209-2"/>
<property type="nucleotide sequence ID" value="NM_001130691.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001124164.1">
<molecule id="Q08209-3"/>
<property type="nucleotide sequence ID" value="NM_001130692.1"/>
</dbReference>
<dbReference type="PDB" id="1AUI">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A=1-521"/>
</dbReference>
<dbReference type="PDB" id="1M63">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="A/E=1-372"/>
</dbReference>
<dbReference type="PDB" id="1MF8">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.10"/>
<property type="chains" value="A=20-392"/>
</dbReference>
<dbReference type="PDB" id="2JOG">
<property type="method" value="NMR"/>
<property type="chains" value="A=21-347"/>
</dbReference>
<dbReference type="PDB" id="2JZI">
<property type="method" value="NMR"/>
<property type="chains" value="B=391-414"/>
</dbReference>
<dbReference type="PDB" id="2P6B">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A/C=1-380"/>
</dbReference>
<dbReference type="PDB" id="2R28">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.86"/>
<property type="chains" value="C/D=389-413"/>
</dbReference>
<dbReference type="PDB" id="2W73">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="K/L/M/O=395-411"/>
</dbReference>
<dbReference type="PDB" id="3LL8">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/C=14-370"/>
</dbReference>
<dbReference type="PDB" id="4F0Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A=1-370"/>
</dbReference>
<dbReference type="PDB" id="4Q5U">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="C=391-414"/>
</dbReference>
<dbReference type="PDB" id="5C1V">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.35"/>
<property type="chains" value="A/B=2-346"/>
</dbReference>
<dbReference type="PDB" id="5SVE">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.60"/>
<property type="chains" value="A=1-370"/>
</dbReference>
<dbReference type="PDB" id="6NUC">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1-370"/>
</dbReference>
<dbReference type="PDB" id="6NUF">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A=1-370"/>
</dbReference>
<dbReference type="PDB" id="6NUU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=1-370"/>
</dbReference>
<dbReference type="PDBsum" id="1AUI"/>
<dbReference type="PDBsum" id="1M63"/>
<dbReference type="PDBsum" id="1MF8"/>
<dbReference type="PDBsum" id="2JOG"/>
<dbReference type="PDBsum" id="2JZI"/>
<dbReference type="PDBsum" id="2P6B"/>
<dbReference type="PDBsum" id="2R28"/>
<dbReference type="PDBsum" id="2W73"/>
<dbReference type="PDBsum" id="3LL8"/>
<dbReference type="PDBsum" id="4F0Z"/>
<dbReference type="PDBsum" id="4Q5U"/>
<dbReference type="PDBsum" id="5C1V"/>
<dbReference type="PDBsum" id="5SVE"/>
<dbReference type="PDBsum" id="6NUC"/>
<dbReference type="PDBsum" id="6NUF"/>
<dbReference type="PDBsum" id="6NUU"/>
<dbReference type="BMRB" id="Q08209"/>
<dbReference type="SMR" id="Q08209"/>
<dbReference type="BioGRID" id="111522">
<property type="interactions" value="86"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1003">
<property type="entry name" value="Calcineurin-Calmodulin complex, alpha-R1 variant"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1048">
<property type="entry name" value="Calcineurin-Calmodulin complex, alpha-R2 variant"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-1114">
<property type="entry name" value="Calcineurin-Calmodulin-AKAP5 complex, alpha-R2 variant"/>
</dbReference>
<dbReference type="ComplexPortal" id="CPX-674">
<property type="entry name" value="Calcineurin-Calmodulin-AKAP5 complex, alpha-R1 variant"/>
</dbReference>
<dbReference type="CORUM" id="Q08209"/>
<dbReference type="DIP" id="DIP-6095N"/>
<dbReference type="ELM" id="Q08209"/>
<dbReference type="IntAct" id="Q08209">
<property type="interactions" value="56"/>
</dbReference>
<dbReference type="MINT" id="Q08209"/>
<dbReference type="STRING" id="9606.ENSP00000378323"/>
<dbReference type="BindingDB" id="Q08209"/>
<dbReference type="ChEMBL" id="CHEMBL4445"/>
<dbReference type="DrugBank" id="DB08231">
<property type="generic name" value="Myristic acid"/>
</dbReference>
<dbReference type="DrugCentral" id="Q08209"/>
<dbReference type="DEPOD" id="PPP3CA"/>
<dbReference type="iPTMnet" id="Q08209"/>
<dbReference type="MetOSite" id="Q08209"/>
<dbReference type="PhosphoSitePlus" id="Q08209"/>
<dbReference type="SwissPalm" id="Q08209"/>
<dbReference type="BioMuta" id="PPP3CA"/>
<dbReference type="DMDM" id="1352673"/>
<dbReference type="EPD" id="Q08209"/>
<dbReference type="jPOST" id="Q08209"/>
<dbReference type="MassIVE" id="Q08209"/>
<dbReference type="MaxQB" id="Q08209"/>
<dbReference type="PaxDb" id="Q08209"/>
<dbReference type="PeptideAtlas" id="Q08209"/>
<dbReference type="PRIDE" id="Q08209"/>
<dbReference type="ProteomicsDB" id="2488"/>
<dbReference type="ProteomicsDB" id="58579">
<molecule id="Q08209-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58580">
<molecule id="Q08209-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="58581">
<molecule id="Q08209-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="88"/>
<dbReference type="Antibodypedia" id="2193">
<property type="antibodies" value="565 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="5530"/>
<dbReference type="Ensembl" id="ENST00000323055">
<molecule id="Q08209-3"/>
<property type="protein sequence ID" value="ENSP00000320580"/>
<property type="gene ID" value="ENSG00000138814"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394853">
<molecule id="Q08209-2"/>
<property type="protein sequence ID" value="ENSP00000378322"/>
<property type="gene ID" value="ENSG00000138814"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000394854">
<molecule id="Q08209-1"/>
<property type="protein sequence ID" value="ENSP00000378323"/>
<property type="gene ID" value="ENSG00000138814"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000512215">
<molecule id="Q08209-4"/>
<property type="protein sequence ID" value="ENSP00000422781"/>
<property type="gene ID" value="ENSG00000138814"/>
</dbReference>
<dbReference type="GeneID" id="5530"/>
<dbReference type="KEGG" id="hsa:5530"/>
<dbReference type="UCSC" id="uc003hvu.3">
<molecule id="Q08209-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5530"/>
<dbReference type="DisGeNET" id="5530"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000138814.16"/>
<dbReference type="GeneCards" id="PPP3CA"/>
<dbReference type="HGNC" id="HGNC:9314">
<property type="gene designation" value="PPP3CA"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000138814">
<property type="expression patterns" value="Tissue enhanced (brain)"/>
</dbReference>
<dbReference type="MalaCards" id="PPP3CA"/>
<dbReference type="MIM" id="114105">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="MIM" id="617711">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="618265">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q08209"/>
<dbReference type="OpenTargets" id="ENSG00000138814"/>
<dbReference type="Orphanet" id="178469">
<property type="disease" value="Autosomal dominant non-syndromic intellectual disability"/>
</dbReference>
<dbReference type="Orphanet" id="565858">
<property type="disease" value="Craniosynostosis-microretrognathia-severe intellectual disability syndrome"/>
</dbReference>
<dbReference type="Orphanet" id="442835">
<property type="disease" value="Undetermined early-onset epileptic encephalopathy"/>
</dbReference>
<dbReference type="PharmGKB" id="PA33678"/>
<dbReference type="eggNOG" id="KOG0375">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000156306"/>
<dbReference type="HOGENOM" id="CLU_962966_0_0_1"/>
<dbReference type="InParanoid" id="Q08209"/>
<dbReference type="KO" id="K04348"/>
<dbReference type="OMA" id="WSLKIWY"/>
<dbReference type="PhylomeDB" id="Q08209"/>
<dbReference type="TreeFam" id="TF105557"/>
<dbReference type="PathwayCommons" id="Q08209"/>
<dbReference type="Reactome" id="R-HSA-180024">
<property type="pathway name" value="DARPP-32 events"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2025928">
<property type="pathway name" value="Calcineurin activates NFAT"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-2871809">
<property type="pathway name" value="FCERI mediated Ca+2 mobilization"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-4086398">
<property type="pathway name" value="Ca2+ pathway"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-5607763">
<property type="pathway name" value="CLEC7A (Dectin-1) induces NFAT activation"/>
</dbReference>
<dbReference type="SIGNOR" id="Q08209"/>
<dbReference type="BioGRID-ORCS" id="5530">
<property type="hits" value="1 hit in 872 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="PPP3CA">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q08209"/>
<dbReference type="GeneWiki" id="PPP3CA"/>
<dbReference type="GenomeRNAi" id="5530"/>
<dbReference type="Pharos" id="Q08209">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q08209"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 4"/>
</dbReference>
<dbReference type="RNAct" id="Q08209">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000138814">
<property type="expression patterns" value="Expressed in caudate nucleus and 253 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q08209">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q08209">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005955">
<property type="term" value="C:calcineurin complex"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043197">
<property type="term" value="C:dendritic spine"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019897">
<property type="term" value="C:extrinsic component of plasma membrane"/>
<property type="evidence" value="ECO:0000305"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0098978">
<property type="term" value="C:glutamatergic synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0005654">
<property type="term" value="C:nucleoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042383">
<property type="term" value="C:sarcolemma"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0098685">
<property type="term" value="C:Schaffer collateral - CA1 synapse"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0036057">
<property type="term" value="C:slit diaphragm"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030018">
<property type="term" value="C:Z disc"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0051117">
<property type="term" value="F:ATPase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0005509">
<property type="term" value="F:calcium ion binding"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005516">
<property type="term" value="F:calmodulin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033192">
<property type="term" value="F:calmodulin-dependent protein phosphatase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016018">
<property type="term" value="F:cyclosporin A binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008144">
<property type="term" value="F:drug binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046983">
<property type="term" value="F:protein dimerization activity"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004722">
<property type="term" value="F:protein serine/threonine phosphatase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0044877">
<property type="term" value="F:protein-containing complex binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007568">
<property type="term" value="P:aging"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007420">
<property type="term" value="P:brain development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0097720">
<property type="term" value="P:calcineurin-mediated signaling"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0033173">
<property type="term" value="P:calcineurin-NFAT signaling cascade"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006816">
<property type="term" value="P:calcium ion transport"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0014898">
<property type="term" value="P:cardiac muscle hypertrophy in response to stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035690">
<property type="term" value="P:cellular response to drug"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071333">
<property type="term" value="P:cellular response to glucose stimulus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0016311">
<property type="term" value="P:dephosphorylation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060079">
<property type="term" value="P:excitatory postsynaptic potential"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0038095">
<property type="term" value="P:Fc-epsilon receptor signaling pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0000082">
<property type="term" value="P:G1/S transition of mitotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0033555">
<property type="term" value="P:multicellular organismal response to stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0035562">
<property type="term" value="P:negative regulation of chromatin binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0050774">
<property type="term" value="P:negative regulation of dendrite morphogenesis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0046676">
<property type="term" value="P:negative regulation of insulin secretion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:1903799">
<property type="term" value="P:negative regulation of production of miRNAs involved in gene silencing by miRNA"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070262">
<property type="term" value="P:peptidyl-serine dephosphorylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1903244">
<property type="term" value="P:positive regulation of cardiac muscle hypertrophy in response to stress"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045785">
<property type="term" value="P:positive regulation of cell adhesion"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0030335">
<property type="term" value="P:positive regulation of cell migration"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="ARUK-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:1905205">
<property type="term" value="P:positive regulation of connective tissue replacement"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051091">
<property type="term" value="P:positive regulation of DNA-binding transcription factor activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045807">
<property type="term" value="P:positive regulation of endocytosis"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0099170">
<property type="term" value="P:postsynaptic modulation of chemical synaptic transmission"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0006470">
<property type="term" value="P:protein dephosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006606">
<property type="term" value="P:protein import into nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0001975">
<property type="term" value="P:response to amphetamine"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0051592">
<property type="term" value="P:response to calcium ion"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048741">
<property type="term" value="P:skeletal muscle fiber development"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0043403">
<property type="term" value="P:skeletal muscle tissue regeneration"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042110">
<property type="term" value="P:T cell activation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014883">
<property type="term" value="P:transition between fast and slow fiber"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0007223">
<property type="term" value="P:Wnt signaling pathway, calcium modulating pathway"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0042060">
<property type="term" value="P:wound healing"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="CDD" id="cd07416">
<property type="entry name" value="MPP_PP2B"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="DisProt" id="DP00092"/>
<dbReference type="Gene3D" id="3.60.21.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="IDEAL" id="IID00069"/>
<dbReference type="InterPro" id="IPR004843">
<property type="entry name" value="Calcineurin-like_PHP_ApaH"/>
</dbReference>
<dbReference type="InterPro" id="IPR029052">
<property type="entry name" value="Metallo-depent_PP-like"/>
</dbReference>
<dbReference type="InterPro" id="IPR041751">
<property type="entry name" value="MPP_PP2B"/>
</dbReference>
<dbReference type="InterPro" id="IPR043360">
<property type="entry name" value="PP2B"/>
</dbReference>
<dbReference type="InterPro" id="IPR006186">
<property type="entry name" value="Ser/Thr-sp_prot-phosphatase"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR45673">
<property type="entry name" value="PTHR45673"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00149">
<property type="entry name" value="Metallophos"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PRINTS" id="PR00114">
<property type="entry name" value="STPHPHTASE"/>
</dbReference>
<dbReference type="SMART" id="SM00156">
<property type="entry name" value="PP2Ac"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00125">
<property type="entry name" value="SER_THR_PHOSPHATASE"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0112">Calmodulin-binding</keyword>
<keyword id="KW-0965">Cell junction</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0989">Craniosynostosis</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0242">Dwarfism</keyword>
<keyword id="KW-0887">Epilepsy</keyword>
<keyword id="KW-0378">Hydrolase</keyword>
<keyword id="KW-0408">Iron</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0991">Mental retardation</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0944">Nitration</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0904">Protein phosphatase</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0770">Synapse</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="initiator methionine" description="Removed" evidence="11">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform" id="PRO_0000058822">
<location>
<begin position="2"/>
<end position="521"/>
</location>
</feature>
<feature type="region of interest" description="Catalytic" evidence="46">
<location>
<begin position="56"/>
<end position="340"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with PxIxIF motif in substrate" evidence="24 25 31 32 34">
<location>
<begin position="327"/>
<end position="336"/>
</location>
</feature>
<feature type="region of interest" description="Calcineurin B binding" evidence="19 20 24 32 35 40">
<location>
<begin position="341"/>
<end position="369"/>
</location>
</feature>
<feature type="region of interest" description="Calmodulin-binding" evidence="27 30 33 41">
<location>
<begin position="392"/>
<end position="406"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory segment" evidence="13">
<location>
<begin position="407"/>
<end position="414"/>
</location>
</feature>
<feature type="region of interest" description="Autoinhibitory domain" evidence="40">
<location>
<begin position="465"/>
<end position="487"/>
</location>
</feature>
<feature type="short sequence motif" description="SAPNY motif" evidence="47">
<location>
<begin position="307"/>
<end position="311"/>
</location>
</feature>
<feature type="active site" description="Proton donor" evidence="48">
<location>
<position position="151"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron" evidence="1 2 4 6 8 9 19 24 31 34 35 40">
<location>
<position position="90"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron; via tele nitrogen" evidence="1 2 4 6 8 9 19 24 31 34 35 40">
<location>
<position position="92"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Iron" evidence="1 2 4 6 8 9 19 24 31 34 35 40">
<location>
<position position="118"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="1 2 4 6 8 9 19 24 31 34 35 40">
<location>
<position position="118"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="1 2 4 6 8 9 19 24 31 34 35 40">
<location>
<position position="150"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; via tele nitrogen" evidence="1 2 4 6 8 9 19 24 31 34 35 40">
<location>
<position position="199"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc; via pros nitrogen" evidence="1 2 4 6 8 9 19 24 31 34 35 40">
<location>
<position position="281"/>
</location>
</feature>
<feature type="site" description="Interaction with PxVP motif in substrate" evidence="32 35">
<location>
<position position="352"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylserine" evidence="11">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="3'-nitrotyrosine" evidence="15">
<location>
<position position="224"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="16">
<location>
<position position="469"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="492"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_054467" evidence="45">
<location>
<begin position="20"/>
<end position="86"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_047755" evidence="44">
<location>
<begin position="87"/>
<end position="318"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_043378" evidence="44">
<location>
<begin position="318"/>
<end position="359"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2 and isoform 3." id="VSP_018562" evidence="42 43 44">
<location>
<begin position="448"/>
<end position="457"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE1; dbSNP:rs1553925558." id="VAR_080348" evidence="36 38">
<original>H</original>
<variation>R</variation>
<location>
<position position="92"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE1." id="VAR_081900" evidence="38">
<original>N</original>
<variation>I</variation>
<location>
<position position="150"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE1." id="VAR_081901" evidence="38">
<original>D</original>
<variation>E</variation>
<location>
<position position="234"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE1; dbSNP:rs199706529." id="VAR_080349" evidence="36">
<original>H</original>
<variation>Q</variation>
<location>
<position position="281"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE1; dbSNP:rs1553923787." id="VAR_080350" evidence="36">
<original>E</original>
<variation>K</variation>
<location>
<position position="282"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE1." id="VAR_080351" evidence="36">
<location>
<begin position="445"/>
<end position="521"/>
</location>
</feature>
<feature type="sequence variant" description="In IECEE1; unknown pathological significance; dbSNP:rs1553920374." id="VAR_080352" evidence="36">
<original>A</original>
<variation>T</variation>
<location>
<position position="447"/>
</location>
</feature>
<feature type="sequence variant" description="In ACCIID; dbSNP:rs1560567347." id="VAR_081902" evidence="38">
<original>F</original>
<variation>L</variation>
<location>
<position position="470"/>
</location>
</feature>
<feature type="sequence variant" description="In ACCIID; dbSNP:rs1560567337." id="VAR_081903" evidence="38">
<original>A</original>
<variation>T</variation>
<location>
<position position="473"/>
</location>
</feature>
<feature type="mutagenesis site" description="Partial loss of Ca(2+)-mediated transcription factor NFAT activation; when associated with F-341." evidence="34">
<original>Y</original>
<variation>F</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of Ca(2+)-mediated transcription factor NFAT activation; when associated with F-341." evidence="34">
<original>Y</original>
<variation>N</variation>
<variation>A</variation>
<location>
<position position="288"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of Ca(2+)-mediated transcription factor NFAT activation; when associated with F-341." evidence="34">
<location>
<begin position="328"/>
<end position="332"/>
</location>
</feature>
<feature type="mutagenesis site" description="Resistant to cyclosporin A-mediated inhibition. Loss of Ca(2+)-mediated transcription factor NFAT activation; when associated with N-288, A-228 or 328-V--R-332 DEL. Partial loss in Ca(2+)-mediated transcription factor NFAT activation; when associated with F-288." evidence="34">
<original>Y</original>
<variation>F</variation>
<location>
<position position="341"/>
</location>
</feature>
<feature type="strand" evidence="10">
<location>
<begin position="13"/>
<end position="15"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="31"/>
<end position="34"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="43"/>
<end position="51"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="58"/>
<end position="73"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="77"/>
<end position="81"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="83"/>
<end position="88"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="95"/>
<end position="105"/>
</location>
</feature>
<feature type="turn" evidence="10">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="113"/>
<end position="115"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="120"/>
<end position="123"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="126"/>
<end position="139"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="141"/>
<end position="143"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="144"/>
<end position="146"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="154"/>
<end position="159"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="162"/>
<end position="169"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="172"/>
<end position="183"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="188"/>
<end position="191"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="192"/>
<end position="194"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="195"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="206"/>
<end position="208"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="210"/>
<end position="213"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="218"/>
<end position="220"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="223"/>
<end position="225"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="226"/>
<end position="232"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="237"/>
<end position="240"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="247"/>
<end position="250"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="252"/>
<end position="254"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="255"/>
<end position="260"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="262"/>
<end position="271"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="276"/>
<end position="279"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="287"/>
<end position="290"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="298"/>
<end position="306"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="311"/>
<end position="313"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="319"/>
<end position="325"/>
</location>
</feature>
<feature type="strand" evidence="7">
<location>
<begin position="328"/>
<end position="334"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="344"/>
<end position="346"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="349"/>
<end position="369"/>
</location>
</feature>
<feature type="helix" evidence="5">
<location>
<begin position="396"/>
<end position="409"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="470"/>
<end position="477"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="478"/>
<end position="481"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1AUI"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1M63"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2JOG"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2P6B"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2W73"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3LL8"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4F0Z"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5C1V"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5SVE"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PDB" id="6NUC"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P16298"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P48452"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P63328"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="P63329"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11114196"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11842093"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12218175"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12357034"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12809556"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15454081"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15671020"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17498738"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17502104"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17923693"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18384083"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18838687"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19154138"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19404396"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22343722"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23468591"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25144868"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26248042"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27974827"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="28942967"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29043977"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="29432562"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="30611118"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8524402"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source ref="30"/>
</evidence>
<evidence key="42" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="20590401"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="21647268"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000305"/>
<evidence key="47" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="26248042"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="8524402"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000312">
<source>
<dbReference type="HGNC" id="HGNC:9314"/>
</source>
</evidence>
<sequence length="521" mass="58688" checksum="16480D62DDBF1F40" modified="1996-02-01" version="1">MSEPKAIDPKLSTTDRVVKAVPFPPSHRLTAKEVFDNDGKPRVDILKAHLMKEGRLEESVALRIITEGASILRQEKNLLDIDAPVTVCGDIHGQFFDLMKLFEVGGSPANTRYLFLGDYVDRGYFSIECVLYLWALKILYPKTLFLLRGNHECRHLTEYFTFKQECKIKYSERVYDACMDAFDCLPLAALMNQQFLCVHGGLSPEINTLDDIRKLDRFKEPPAYGPMCDILWSDPLEDFGNEKTQEHFTHNTVRGCSYFYSYPAVCEFLQHNNLLSILRAHEAQDAGYRMYRKSQTTGFPSLITIFSAPNYLDVYNNKAAVLKYENNVMNIRQFNCSPHPYWLPNFMDVFTWSLPFVGEKVTEMLVNVLNICSDDELGSEEDGFDGATAAARKEVIRNKIRAIGKMARVFSVLREESESVLTLKGLTPTGMLPSGVLSGGKQTLQSATVEAIEADEAIKGFSPQHKITSFEEAKGLDRINERMPPRRDAMPSDANLNSINKALTSETNGTDSNGSNSSNIQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

